169 related articles for article (PubMed ID: 21138945)
1. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas.
Barrow J; Adamowicz-Brice M; Cartmill M; MacArthur D; Lowe J; Robson K; Brundler MA; Walker DA; Coyle B; Grundy R
Neuro Oncol; 2011 Feb; 13(2):212-22. PubMed ID: 21138945
[TBL] [Abstract][Full Text] [Related]
2. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.
Deng MY; Sturm D; Pfaff E; Sill M; Stichel D; Balasubramanian GP; Tippelt S; Kramm C; Donson AM; Green AL; Jones C; Schittenhelm J; Ebinger M; Schuhmann MU; Jones BC; van Tilburg CM; Wittmann A; Golanov A; Ryzhova M; Ecker J; Milde T; Witt O; Sahm F; Reuss D; Sumerauer D; Zamecnik J; Korshunov A; von Deimling A; Pfister SM; Jones DTW
Nat Commun; 2021 Sep; 12(1):5530. PubMed ID: 34545083
[TBL] [Abstract][Full Text] [Related]
4. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
Martinho O; Longatto-Filho A; Lambros MB; Martins A; Pinheiro C; Silva A; Pardal F; Amorim J; Mackay A; Milanezi F; Tamber N; Fenwick K; Ashworth A; Reis-Filho JS; Lopes JM; Reis RM
Br J Cancer; 2009 Sep; 101(6):973-82. PubMed ID: 19707201
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.
Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM
Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287
[TBL] [Abstract][Full Text] [Related]
6. Reliability assessment of methylthioadenosine phosphorylase immunohistochemistry as a surrogate biomarker for CDKN2A homozygous deletion in adult-type IDH-mutant diffuse gliomas.
Gundogdu F; Babaoglu B; Soylemezoglu F
J Neuropathol Exp Neurol; 2024 Jan; 83(2):107-114. PubMed ID: 38109891
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways and mesenchymal transition in pediatric high-grade glioma.
Meel MH; Schaper SA; Kaspers GJL; Hulleman E
Cell Mol Life Sci; 2018 Mar; 75(5):871-887. PubMed ID: 29164272
[TBL] [Abstract][Full Text] [Related]
8. p16 Immunohistochemistry as a Screening Tool for Homozygous CDKN2A Deletions in CNS Tumors.
Zschernack V; Andreiuolo F; Dörner E; Wiedey A; Jünger ST; Friker LL; Maruccia R; Pietsch T
Am J Surg Pathol; 2024 Jan; 48(1):46-53. PubMed ID: 37947008
[TBL] [Abstract][Full Text] [Related]
9. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.
Mackay A; Burford A; Carvalho D; Izquierdo E; Fazal-Salom J; Taylor KR; Bjerke L; Clarke M; Vinci M; Nandhabalan M; Temelso S; Popov S; Molinari V; Raman P; Waanders AJ; Han HJ; Gupta S; Marshall L; Zacharoulis S; Vaidya S; Mandeville HC; Bridges LR; Martin AJ; Al-Sarraj S; Chandler C; Ng HK; Li X; Mu K; Trabelsi S; Brahim DH; Kisljakov AN; Konovalov DM; Moore AS; Carcaboso AM; Sunol M; de Torres C; Cruz O; Mora J; Shats LI; Stavale JN; Bidinotto LT; Reis RM; Entz-Werle N; Farrell M; Cryan J; Crimmins D; Caird J; Pears J; Monje M; Debily MA; Castel D; Grill J; Hawkins C; Nikbakht H; Jabado N; Baker SJ; Pfister SM; Jones DTW; Fouladi M; von Bueren AO; Baudis M; Resnick A; Jones C
Cancer Cell; 2017 Oct; 32(4):520-537.e5. PubMed ID: 28966033
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.
Anderson JL; Muraleedharan R; Oatman N; Klotter A; Sengupta S; Waclaw RR; Wu J; Drissi R; Miles L; Raabe EH; Weirauch ML; Fouladi M; Chow LM; Hoffman L; DeWire M; Dasgupta B
Neuro Oncol; 2017 Aug; 19(8):1068-1078. PubMed ID: 28339768
[TBL] [Abstract][Full Text] [Related]
11. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.
Lin GL; Nagaraja S; Filbin MG; Suvà ML; Vogel H; Monje M
Acta Neuropathol Commun; 2018 Jun; 6(1):51. PubMed ID: 29954445
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma.
Carvalho D; Mackay A; Bjerke L; Grundy RG; Lopes C; Reis RM; Jones C
Acta Neuropathol Commun; 2014 Feb; 2():23. PubMed ID: 24548782
[TBL] [Abstract][Full Text] [Related]
13. Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models.
Deland K; Starr BF; Mercer JS; Byemerwa J; Crabtree DM; Williams NT; Luo L; Ma Y; Chen M; Becher OJ; Kirsch DG
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32990677
[TBL] [Abstract][Full Text] [Related]
14. Thalamic high-grade gliomas in children: a distinct clinical subset?
Kramm CM; Butenhoff S; Rausche U; Warmuth-Metz M; Kortmann RD; Pietsch T; Gnekow A; Jorch N; Janssen G; Berthold F; Wolff JE
Neuro Oncol; 2011 Jun; 13(6):680-9. PubMed ID: 21636712
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.
Ross JL; Chen Z; Herting CJ; Grabovska Y; Szulzewsky F; Puigdelloses M; Monterroza L; Switchenko J; Wadhwani NR; Cimino PJ; Mackay A; Jones C; Read RD; MacDonald TJ; Schniederjan M; Becher OJ; Hambardzumyan D
Brain; 2021 Feb; 144(1):53-69. PubMed ID: 33300045
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis.
Lowder L; Hauenstein J; Woods A; Chen HR; Rupji M; Kowalski J; Olson JJ; Saxe D; Schniederjan M; Neill S; Weinberg B; Sengupta S
J Neurooncol; 2019 Jul; 143(3):381-392. PubMed ID: 31073965
[TBL] [Abstract][Full Text] [Related]
17. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Khadka P; Reitman ZJ; Lu S; Buchan G; Gionet G; Dubois F; Carvalho DM; Shih J; Zhang S; Greenwald NF; Zack T; Shapira O; Pelton K; Hartley R; Bear H; Georgis Y; Jarmale S; Melanson R; Bonanno K; Schoolcraft K; Miller PG; Condurat AL; Gonzalez EM; Qian K; Morin E; Langhnoja J; Lupien LE; Rendo V; Digiacomo J; Wang D; Zhou K; Kumbhani R; Guerra Garcia ME; Sinai CE; Becker S; Schneider R; Vogelzang J; Krug K; Goodale A; Abid T; Kalani Z; Piccioni F; Beroukhim R; Persky NS; Root DE; Carcaboso AM; Ebert BL; Fuller C; Babur O; Kieran MW; Jones C; Keshishian H; Ligon KL; Carr SA; Phoenix TN; Bandopadhayay P
Nat Commun; 2022 Feb; 13(1):604. PubMed ID: 35105861
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings.
Hammad R; Nobre L; Ryall S; Arnoldo A; Siddaway R; Bennett J; Tabori U; Hawkins C
JCO Glob Oncol; 2024 May; 10():e2300269. PubMed ID: 38754050
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature.
Raghu ALB; Chen JA; Valdes PA; Essayed W; Claus E; Arnaout O; Smith TR; Chiocca EA; Peruzzi PP; Bernstock JD
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612169
[TBL] [Abstract][Full Text] [Related]
20. Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development.
Bax DA; Little SE; Gaspar N; Perryman L; Marshall L; Viana-Pereira M; Jones TA; Williams RD; Grigoriadis A; Vassal G; Workman P; Sheer D; Reis RM; Pearson AD; Hargrave D; Jones C
PLoS One; 2009; 4(4):e5209. PubMed ID: 19365568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
